Broker Ratings

Doximity, Inc. Share Price Target ‘$56.75’, now 6.0% Upside Potential

Doximity, Inc. which can be found using ticker (DOCS) now have 16 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between $75.00 and $31.00 suggesting an average analyst share price target price of $56.75. (at the time of writing). Now with the previous closing price of $53.54 this indicates there is a potential upside of 6.0%. The day 50 moving average is $45.37 and the 200 moving average now moves to $33.02. The market capitalization for the company is 9.97B. The price for the stock stands currently at: $53.39 USD

The potential market cap would be $10,565,088,304 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 61.37, revenue per share of $2.78 and a 11.83% return on assets.

Doximity, Inc. provides a digital platform for United States (U.S) medical professionals. The Company’s cloud-based platform provides tools to its members, which help them to collaborate with colleagues, coordinate patient care, conduct virtual patient visits, stay up-to-date with medical news and research, and manage careers. The Company supports physicians in practice of medicine with mobile and clinical workflow tools, such as voice and video telehealth, secure messaging and digital faxing. The Company’s platform offers marketing, hiring, and telehealth solutions. Its marketing solutions enable pharmaceutical and health system customers to get content, services, and peer connections to medical professionals through a variety of modules. Its hiring solutions provide digital recruiting capabilities to health systems and medical recruiting firms. Its telehealth solutions consist of software tools that include voice and video dialers, designed to connect patients with care providers.

Share on:
Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

    Dr. Martens appoints Berenberg as Joint Corporate Broker

    Dr. Martens plc has appointed Berenberg as a joint corporate broker with immediate effect, working alongside Investec and Goldman Sachs.

    Dr. Martens Plc expands into UAE and Latin America through new partnerships

    Dr. Martens has signed a distribution deal with Beside Group to enter the UAE market for the first time and partnered with Crosby in Latin America, which has opened stores in Argentina and Chile.

      Search

      Search